Abstract. Thrombospondin is a 420,000-D glycoprotein that has recently been shown to have several properties in common with the members of a class of adhesive proteins. To characterize further the adhesive properties of thrombospondin, we have studied its ability to support cell attachment. Thrombospondin adsorbed to plastic dishes supports the attachment of human endothelial and smooth muscle cells and the monocyte-like cell line (U937) as well as normal rat kidney cells. The majority of attached cells do not spread on the solid-phase thrombospondin. The attachment of all four cell types to thrombospondin is abolished if the assay is performed in the presence of EGTA, although the cells still attach to fibronectin. If thrombospondin is adsorbed to the dishes in the presence of EGTA and then washed with buffer containing calcium before addition of the cells, attachment is still markedly inhibited, indicating that calcium affects the conformation and function of thrombospondin. Attachment of all four cell types is also markedly inhibited by the synthetic peptides gly-arg-gly-asp-ser-pro (GRG-DSP) and gly-arg-gly-asp-ala-cys (GRGDAC) but not by the control peptide gly-arg-gly-glu-ser-pro (GRG-ESP). Affinity chromatography of n-octylglucoside extracts of surface-labeled endothelial cells or smooth muscle cells on thrombospondin-Sepharose and GRG-DSP-Affigel columns was used to identify an integrin complex related to glycoprotein IIb-IIIa as an RGDdependent receptor for thrombospondin. In addition, a monoclonal antibody (LM609) that blocks attachment of endothelial cells to vitronectin, fibrinogen, and von Willebrand factor also inhibits attachment of endothelial cells to thrombospondin. These data indicate that the attachment of cells to thrombospondin is mediated by RGD and calcium-dependent mechanisms and is conistent with the hypothesis that the GRGDAC sequence in thrombospondin is a site for interaction with an integrin receptor of the 133 subclass.
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T
HROMBOSPONDIN is a high molecular weight glycoprotein that is synthesized and secreted by various cells in culture (see Lawler, 1986 for a review). Thrombospondin is also secreted by blood platelets at the site of vascular damage (Lawler, 1986) . In terms of its structure and functions, thrombospondin is similar to the members of the class of adhesive proteins. Our recent determination of the amino acid sequence of thrombospondin revealed the presence of the sequence arg-gly-asp-ala (RGDA) in a region of the molecule designated as the last type 3 repeat (Lawler and Hynes, 1986) . The type 3 repeats are homologous with the calcium binding sites of calmodulin and parvalbumin (Lawler and Hynes, 1986) . Thrombospondin has been shown to bind calcium by a cooperative mechanism with an apparent dissociation constant of 120 l.tM (Lawler and Simons, 1983) . In addition, a higher affinity (0.1 gM) interacDr. Jack Lawler's present address is Department of Pathology, Brigham and Women's Hospital, Thorn Bioscience Research Building, 3rd floor, 20 Shattuck Street, Boston, MA 02115. tion can be detected with monoclonal antibodies . The binding of calcium to thrombospondin results in a profound conformational change (Lawler and Simons, 1983; Lawler et al., 1985; Galvin et al., 1985; Dixit et al., 1986) . The localization of this conformational change, by electron microscopy, agrees well with the location of the type 3 repeats based on amino acid sequence data (Lawler et al., 1985; Galvin et al., 1985; Lawler and Hynes, 1986; Dixit et al., 1986) .
The RGD sequence has been shown to be present in the members of a class of adhesive proteins that mediate cell attachment (see Ruoslahti and Pierschbacher, 1986 for a review). A family of cell surface receptor complexes, designated integrins, has been identified which bind proteins containing this sequence (see Hynes, 1987, and Pierschbacher, 1987 for reviews) . Cell attachment mediated by the integrin family of receptors is frequently specifically inhibited by synthetic peptides which include the RGD sequence (Pierschbacher and Ruoslahti, 1984a,b; Yamada and Kennedy, 1984; Ruoslahti and Pierschbacher, 1986) . The integrins are composed of a and 13 subunits that form complexes through noncovalent associations. There are three distinct 13 subunits each of which can associate with several different ¢t subunits (Hynes, 1987; Ginsberg et al., 1988; Phillips et al., 1988) . The members of the 133 or cytoadhesin subfamily have the same 13 subunit, designated integrin 133 or GPIIIa. At least two distinct ¢t subunits that associate with the integrin 133 subunit have been identified to date. The vitronectin receptor tx subunit is present on MG63 osteosarcoma cells (Pytela et al., 1986) . When this receptor is purified and incorporated into liposomes, the liposomes bind specifically to vitronectin. GPIIb is another ¢t subunit that associates with GPIIIa and is found exclusively on platelet membranes (Ginsberg et al., 1988; Suzuki et al., 1987) . The GPIIb-IIIa complex is capable of interacting with fibrinogen, fibronectin, vitronectin, and von Willebrand factor (Plow et al., 1984 (Plow et al., , 1985 . These two ct subunits of ttie 133 subfamily are highly homologous at the amino acid sequence level (Fitzgerald et al., 1987; Poncz et al., 1987) . They are each composed of a heavy chain with an apparent molecular mass of 125,000-130,000 D and a light chain with a molecular mass of 25,000 D (Phillips et al., 1988) .
A GPIIb-IIIa-like integrin complex is found on the surface of many cell types, including endothelial cells, smooth muscle cells, and melanoma cells (Thiagarajan et al., 1985; Fitzgerald et al., 1985; Leeksma et al., 1986; Newman et al., 1986; Plow et al., 1986; Charo et al., 1986) . The 13 subunit of this complex is also GPIIIa or integrin 133 . Some of the antibody preparations that have been raised against GPIIb-IIIa also react with the GPIIb-IIIa-like molecules on endothelial cells and inhibit the attachment of endothelial cells to fibrinogen, vitronectin, and von Willebrand factor (Charo et al., 1987; Cheresh, 1987; Chen et al., 1987) . Thus, in terms of ligand specificity, the adhesion receptor on endothelial cells is similar to platelet GPIIb-IIIa in that it can interact with fibrinogen, von Willebrand factor, and vitronectin.
Several lines of investigation have demonstrated that thrombospondin is capable of interacting with cell surfaces. Thrombospondin binds to a low number of receptors in resting platelets (Wolff et al., 1986) . After thrombin treatment of the platelets, a 10-fold increase in the number of receptor sites is observed (Wolff et al., 1986) . Maximal binding activity is observed in the presence of calcium (Wolff et al., 1986; Aiken et al., 1987) . Thrombospondin has also been shown to bind to mouse peritoneal macrophages and to cells of the monocyte-like human cell line U937 . The binding of thrombospondin to these cell types is divalent cation-dependent . Recently, an 88,000-D membrane glycoprotein that is present in platelets, endothelial cells, monocytes, and several human tumor cell lines has been reported to function as a receptor for thrombospondin (Asch et al., 1987) .
Platelet thrombospondin has been reported to support attachment of human squamous carcinoma cells, human melanoma cells, human platelets, human fibroblasts, bovine endothelial cells, and porcine epithelial cells (Varani et al., 1986; Roberts et al., 1987; Tuszynski et al., 1987) . Cell spreading on the thrombospondin substrates varies considerably for the various cell types and lines (Varani et al., 1986; Roberts et al., 1987; Tuszynski et al., 1987) . Human G361 melanoma cells spread on thrombospondin substrates (Roberts et al., 1987) . Roberts et al. (1987) have found that the heparin-binding domain must be present for thrombospondin to support spreading. By contrast, the 18,000-D COOHterminal portion of the molecule has been found to be essential for cell attachment (Roberts et al., 1987) . In this paper, we report that thrombospondin supports attachment of human endothelial cells, human smooth muscle cells, human U937 cells, and normal rat kidney (NRK) t cells by RGD and calcium-dependent mechanisms. In addition, the glycoprotein IIb-IIIa-like molecules on endothelial cells and smooth muscle cells are identified as a receptor for RGDdependent binding of thrombospondin.
Materials and Methods

Preparation of Protein Substrates
Human platelet thrombospondin and human plasma fibronectin were purified and iodinated as described previously (Engvall and Ruoslahti, 1977; Lawler et al., 1985) . Human vitronectin was obtained from CalbiochemBehring Corp. (La Jolla, CA) and human fibrinogen was obtained from Kabi Vitrnm (Stockholm, Sweden). BSA (Sigma RIA grade) was dissolved in 10 mM Hepes (pH 7.2), 135 mM NaCl, 3 mM KCI, and 0.5 mM MgC12 (HBS) at a concentration of 2 mg/ml and heated to 70°C for 1 h. After heat treatment, 1 mM CaC12 or 0.5 mM EGTA was added to the BSA solutions. The synthetic polypeptides GRGDSE GRGESE and GRGDAC were obtained from Peninsula Laboratories Inc. (Belmont, CA).
Thrombospondin, fibronectin, vitronectin, or fibrinogen were diluted to 20-40 I.tg/ml in HBS containing either 1 mM CaCl2 or 0.5 mM EGTA and adsorbed to the surface of 35-ram dishes (No. 1008; Falcon Labware, Oxnard, CA) at 37°C for 2 h. To determine the amount of thrombospondin that is adsorbed to the surface of the dishes, thrombospondin was radiolabeled with ~25I-Bolton-Hunter reagent using protocols that are provided by the supplier (DuPont Co., Wilmington, DE). A thrombospondin concentration of 0.02 mg/ml resulted in the adsorption of 1.4 + 0.3 I.tg/cm 2 in either the presence of 1 mM CaCI2 or 0.5 mM EGTA.
After protein adsorption, the dishes were washed three times with 3 ml of HBS containing either 1 mM CaCI2 or 0.5 mM EGTA and 1.5 ml of HBS containing 2 mg/ml BSA, and either 1 mM CaCI2 or 0.5 mM EGTA were added. Synthetic peptides were added at this point to some of the dishes. In some experiments, the proteins were incubated in the dishes at 37°C for 2 h in the presence of 0.5 mM EGTA. The dishes were then washed twice in HBS containing 0.5 mM EGTA and then washed once in HBS containing 1 mM CaCI2 before addition of the cells. In some experiments, 1.5 ml of HBS containing 1 mM CaClz and 2 mg/ml BSA were added to the thrombospondin-coated dishes and then 2.25 ml of HBS, preiummune or anti-thrombospondin antibodies (0.6-0.8 mg/ml) were incubated overnight at 4°C in the dishes. The preimmune and anti-human platetet thrombospondin antisera were fractionated by protein A-Sepharose affinity chromatography as described previously (Lawler et al., 1985) . After incubation, the dishes were emptied and 1.5 ml of HBS containing 1 mM CaCI2 and 2 mg/ml BSA were added before the addition of 1.5 ml of cell suspension.
Attachment Assay
Human umbilical vein and arterial endothelial cells and human arterial smooth muscle cell were grown in culture as described previously (Weinstein and Wenc, 1986) . Human U937 cells were kindly provided by Dr. Livingston Van der Water (Beth Israel Hospital, Boston, MA) and were grown in DME containing 4.5 g/liter glucose and 10% FCS. The NRK cells were grown in DME containing 4.5 g/liter glucose and 5 % FCS. The endothelial, smooth muscle and NRK cells were washed once with 5 ml of HBS and were removed form the flasks with 5 ml of HBS containing 0.1 mg/ml TPCK-trypsin (Worthington Biochemical Corp., Freehold, NJ) at 37°C for 5 rain with continuous agitation. The cell suspension was removed, mixed with 5 ml of FIBS containing 0.5 mg/ml soybean trypsin inhibitor (Sigma Chemical Co., St. Louis, MO) and centrifuged at 400 g for 5 min. The cells were washed three times in HBS containing 0.5 mg/rrd soybean trypsin inhibitor and then resuspended in a volume of HBS to give a final cell count of 0.5-3.3 x 10 s cells/ml. The U937 cells were grown in suspension and were harvested by centrifugation at 400 g for 5 min followed by three washes in HBS. The cell suspension (1.5 ml) was added to each protein-coated dish and the dishes were incubated at 37°C for 2 h. After incubation, the dishes were washed three times with 3 ml of HBS alone or with HBS containing 1 mM CaCI2 or 0.5 mM EGTA. The cells were fixed with 3% paraformaldehyde, stained with Giemsa, and photographed. The number of cells bound was determined by counting representative areas of the photomicrograph.
To determine the effect of the monoclonal antibody LM609 (kindly provided by Dr. David Cheresh, La Jolla Cancer Research Foundation, La Jolla, CA) on attachment, endothelial cells were incubated with varying concentrations of antibody in a total volume of 200 ~tl at 4°C for 1 h. The antibody was purified from ascites by affinity chromatography on a column of protein A-Sepharose (Sigma Chemical Co.). After the incubation, the cell suspension was centrifuged at 400 g for 6 min. The cell pellet was resuspended in 1.5 ml of riBS and added to the protein-coated dishes which were then incubated at 37°C for 1 h, washed, and fixed as described above.
A~nity Chromatography
Endothelial cells or smooth muscle cells in four 100-mm dishes were washed three times in PBS (with 1 mM CaC12 and 1 mM MgC12). The cell layers were then incubated with 0.5 ml of PBS containing 1 mCi u~I, 20 p.g/ml lactoperoxidase, and 0.1 Ulml glucose oxidase. The dishes were rocked continuously for 10 rain at 22°C. The iodination mixture was removed and the cell layers were washed three times with PBS containing 1 mM Nal. The cell layers from all four dishes were solubilized with 1.0 ml of PBS containing 200 mM n-octylglucoside (Boehringer Mannhein Biochemicals, Indianapolis, IN). The extract was incubated at 0°C for 15 rain and then centrifuged for 15 rain at 3,000 g. The supernatant was decanted and applied to either a column (0.8 x 4 cm) of thrombospondin-Sepharose or a column (0.8 x 1 cm) of GRGDSPC-Affi-gel 10. After the sample had entered the columns, the flow was stopped for 1 h. The columns were eluted with 60 ml PBS containing 50 mM n-octylglucoside (buffer A), followed by 2.5 ml of buffer A containing 1 mg/ml of the peptide GRGESE and finally 2.5 ml of buffer A containing 1 mg/ml of the peptide GRGDSP.
Immunoprecipitation lmmunoprecipitation of the various fractions was performed as described by Marcantonio and Hynes (1988) . Protein A-purified monoclonal antibody LMI42 (kindly provided by Dr. David Cheresh) was coupted to Sepharose 4B following standard procedures suggested by the supplier (Pharmacia Fine Chemicals, Piscataway, NJ). 100 ktl of the antibody-Sepharose suspension ("~20 I11 of packed beads) was mixed with 250-500 ttl of sample. After immunoprecipitation, the pellet was solubilized in sample buffer and was subjected to electrophoresis on 3.5-10.0% acrylamide gradient gels (Lawler et al., 1985) .
Results
Attachment of CeUs to Thrombospondin
Human endothelial cells, smooth muscle cells, and U937 cells, as well as NRK cells attach to thrombospondin which is adsorbed to plastic surfaces in the presence of 1 mM CaC12 (Figs. 1 and 3 ). The effect of varying the concentration of thrombospondin used to coat the dishes was assayed with NRK cells. The number of cells that attach increases as the concentration of the thrombospondin solution used to coat the dishes increases up to 25 ~tg/ml (data not shown). From 25 to 75 llg/ml the number of cells that attached remained constant. A thrombospondin concentration of 20 ~tg/ml was used for the remainder of the experiments described in this report. All four of the cell types studied fail to attach to heat-treated BSA (Fig. 1 b) . Less than 5 % of the attached (anchorage-dependent) cells (endothelial, smooth muscle, and NRK) spread on the thrombospondin substrate (Figs. 1-3) . By contrast, the majority of the attached cells spread on fibronectin substrates, when 1 mM CaCI2 is pres- ent ( Figs. 1 and 2) . Preincubation of the thrombospondincoated dishes with protein A-purified polyclonal anti-thrombospondin antibodies reduced the number of attached endothelial, smooth muscle, or NRK cells to 20 + 6.4, 9.4 + 2.1, or 21 + 5.8% of control, respectively. Preincubation of the thrombospondin-coated dishes with the preimmune immunoglobulin did not reduce the number of cells attached (99 + 6 % of control averaged over the three cell types). U937 cells contain immunoglobulin receptors and could not be readily studied in this system (Fleit et al., 1982) .
The Effect of Calcium on the Attachment of CeUs to Thrombospondin
Since calcium modulates the structure of thrombospondin, the effect of calcium on the attachment of the four cell types was investigated. When the thrombospondin is adsorbed to the dishes in the presence of 0.5 mM EGTA and the cell attachment assay is performed in the presence of 0.25 mM EGTA, the attachment of all four cell types is abolished (Fig.  2) . Note that divalent cations are present in this system, which contains 0.25 mM Mg ++. The loss of attachment activity is not due to an inability of thrombospondin to bind to the plastic surface in the presence of EGTA since an equivalent amount of radiolabeled thrombospondin bound to the dishes in either 1 mM CaCI2 or 0.5 mM EGTA (data not shown). Under these experimental conditions the cells are still capable of attaching to fibronectin, albeit at a decreased level (Fig. 2) . The percentage of cells that spread on the fibronectin substrate is markedly reduced in the presence of EGTA. These data indicate that the effect of EGTA may be, at least in part, due to an effect on the cells. To distinguish the effect of calcium on the thrombospondin substrate from its effect on the cells, the thrombospondin was adsorbed to the dishes in the presence of 0.5 mM EGTA and then washed with buffer containing 1 mM CaC12 before the incubation of the ceils in the presence of 0.5 mM calcium. The attachment of endothelial cells, smooth muscle cells, U937 cells, and NRK cells to this substrate was reduced to 1.1 + 0.8, 11 + 2, 0.4 + 0.7, and 20 + 3 % of control values, respectively (Fig. 3) . By contrast, equivalent numbers of attached and spread NRK cells were observed on fibronectin substrates prepared in the presence of 1 mM CaCI2 or 0.5 mM EGTA, when the cells were added in the presence of 0.5 mM CaCI2 (data not shown). Thus, some of the effect of calcium depletion is on the thrombospondin.
The Effect of Synthetic Peptides on the Attachment of CeUs to Thrombospondin
The hexapeptide GRGDSP inhibits the attachment of all four cell types to thrombospondin in a dose-dependent manner (Figs. 4 and 5) . At a concentration of 0.4 mM GRGDSP, the inhibition was >94 % for all the four cell types. By contrast, the synthetic peptide GRGESP had only a small inhibitory effect at the highest concentration (0.4 mM) tested (Figs. 4  and 5) .
Based on the thrombospondin sequence, the peptide GRG-DAC was synthesized and its effect on attachment of the four cell types to thrombospondin was determined. This peptide also inhibited attachment of all four cell types to thrombospondin in a dose-dependent manner (Fig. 5) . A concentration of 0.4 mM GRGDAC reduced the number of endothelial, smooth muscle, U937, or NRK cells, which attached to thrombospondin, to 15 + 7.3, 4.3 -I-3.6, 1.7 + 1.0, or 27 + 2% of control, respectively.
Identification of a RGD-dependent Receptor
To identify the receptor for thrombospondin, endothelial, Iqgure 3. The effect of calcium on the attachment of NRK (a, c, and e) and U937 (b, d , and f) cells to thrombospondin. The dishes were coated with thrombospondin (0.02 mg/ml) in HBS containing either 1 mM CaC12 (a and b) or 0.5 mM EGTA (c-f). The dishes were washed three times in HBS containing either 1 mM CaC12 (a and b) or 0.5 mM EGTA (c and d) as in Fig. 2 . Two additional dishes (e and f) were washed twice in HBS containing 0.5 mM EGTA followed by one wash in HBS containing 1 mM CaC12. BSA solution (2 mg/ml) prepared in HBS containing either 1 mM CaCI2 (a, b, e, and f) or 0.5 mM EGTA (c and d) was added before addition of the cells that were resuspended in HBS. Bar, 200 Ixm. and smooth muscle cell membranes were radiolabeled with t25I-lactoperoxidase, extracted with n-octylgucoside, and applied to a column of thrombospondin-Sepharose. Whereas most of the radiolabeled proteins flow through the column, two proteins with reduced molecular masses of 128,000 and 100,000 D are retarded by the column (Fig. 6 ). Low levels of these proteins continue to be eluted from the column after 20 bed volumes of buffer A. Fig. 6 shows the quantity of the 100,000-D protein that is eluted from the thrombospondin-Sepharose column as a function of fraction number when an endothelial cell extract is applied. A peak in the quantities of both the 128,00-and 100,000-D proteins is eluted with buffer A containing 1 mg/ml of the peptide GRG-DSP (Fig. 6) . SDS-PAGE of the eluted proteins in the absence of reducing agent reveals two bands with molecular masses of 140,000 and 85,000 D (Fig. 7) . The amount of radioactivity that was subjected to electrophoresis at the dye front is decreased in nonreduced samples suggesting that at least one of the high molecular mass bands is linked to a light chain by disulfide bonds. The polypeptides that are isolated from endothelial cells and smooth muscle cells comigrate (Fig. 8) . The polypeptides isolated from endothelial cells on thrombospondin-Sepharose are similar to integrin complexes that are isolated on GRGDSP-Sepharose (Cheresh, 1987) . To establish this identity we have (a) applied extracts of endothelial cells and smooth muscle cells to a column of GRGSPC-Affi-gel and (b) have performed immunoprecipitations with antibodies to a M21 melanoma cell integrin complex with similar electrophoretic properties (Cheresh, 1987) . The polypeptides that are eluted from a GRGDSPC-Afli-gel column with 1 mg/ml GRGDSP comigrate with those eluted from the thrombospondin-Sepharose (Fig. 7) . In addition, the polypeptides that are eluted from the thrombospondinSepharose column, when either endothelial cell or smooth muscle cell extracts are applied to the column, can be immunoprecipitated with monoclonal antibody LM142-Sepharose (Fig. 8) . This antibody is directed against the ct-subunit of an M21 melanoma cell integrin complex and has been shown to immunoprecipitate the GPIIb-IIIa-like complex from human endothelial cells (Cheresh, 1987) .
The Effect of Monoclonal Antibody LM609 on Endothelial Ceil Attachment to Thrombospondin
Monoclonal antibody LM609 also reacts with the integrin complex that is present on M21 melanoma cells and endothelial cells (Cheresh, 1987) . Whereas antibody LM142 does not inhibit attachment of endothelial cells to adhesive proteins, antibody LM609 specifically inhibits attachment of endothelial cells to vitronectin, fibronogen, and yon Willebrand factor (Cheresh, 1987) . A dose-dependent inhibition of attachment of endothelial cells to thrombospondin is observed when the cells are preincubated with varying concentrations of antibody LM609, but not with antibody LM142 (Fig. 9 ). For comparison, the effect of antibody LM609 on attachment of endothelial cells to vitronectin and fibrinogen was also studied. The cellular attachment to vitronectin was inhibited by antibody LM609 to an extent that was quantitatively equivalent to the inhibition of attachment to thrombospondin (Fig. 9) . By contrast, endothelial cell attachment to fibrinogen was completely abolished by the antibody LM609 at all concentrations studied (Fig. 9) .
Discussion
The data presented show that thrombospondin can act as a cell attachment factor for a variety of cells. The attachment to thrombospondin of all four cell types included in this study is abolished if the thrombospondin is adsorbed to the dishes in the presence of EGTA and the cells are incubated in the dishes in the presence of EGTA. That is, attachment to thrombospondin is Ca++-dependent whereas attachment to fibronectin is not. If dishes coated with thrombospondin in the absence of Ca ++ are washed with buffer containing 1 mM CaC12 before the addition of the cells, the attachment activity is partially recovered (10-20% of control) for the NRK and smooth muscle cells, but not for the endothelial or U937 cells (<2% of control). These results show that the major effect of Ca ++ depletion is on the thrombospondin, not the cells, and indicate that, for the most part, the thrombospondin that is adsorbed to the plastic in the presence of EGTA does not revert to the calcium-dependent form upon calcium restoration. The low level of attachment that is observed on restoration of calcium may be due to the ability of some of the thrombospondin molecules to recover or may be due to an effect on the cell surface receptors. In the latter case, a calcium-dependent increase in the receptor's affinity for thrombospondin may partially compensate for the fact that the conformation of the thrombospondin molecules is not correct.
The data presented here also suggest that the GRGDAC sequence of thrombospondin is the functional site for the attachment of the four cell types studied. This sequence occurs in the last type 3 repeating sequence of thrombospondin (Lawler and Hynes, 1986; Lawler and Hynes, 1987) . The sequences of the type 3 repeats are homologous with the calcium-binding sites of calmodulin and parvalbumin. The presence of the GRGDAC sequence in the calcium-binding region of thrombospondin is consistent with the observation that the attachment of cells to thrombospondin is calcium dependent. Calcium may be affecting the activity of the RGD sequence by altering the conformation of thrombospondin in two ways. At the level of the whole molecule, the calciuminduced change in the orientation of the COOH-terminal globular domain may affect the exposure of the RGD site or may affect the juxtaposition of other parts of the thrombospondin molecule that also participate in the interaction with cell surface receptors (Lawler et al., 1985; Galvin et al., 1985; Lawler and Hynes, 1987) . On a local level, calcium may be required to form a loop structure that presents the RGD sequence in a conformation that is recognized by the receptor. We propose that the calcium-binding sites of thrombospondin are loop structures based on their sequence homology with the calcium-binding sites of other proteins of established structure and based on secondary structural analysis using a predictive algorithm (Chou and Fasman, 1978; Kretsinger, 1980) . A schematic diagram of the structure of the type 3 repeat which contains the RGD sequence is shown in Fig. 10 . The or-helix and ~-sheet potentials, calculated using the Chou and Fasman (1978) algorithm, are low throughout the region. By contrast, the loop potential is high in this region as indicated by the averages of the normalized frequencies of amino acid occurrence in omega loops (Leszczynski and Rose, 1986) . A detailed algorithm for the prediction of loops has not been published to date. ~turns with relatively high probability are predicted at the beginning and end of the sequence shown in Fig. l0 (Chou and Fasman, 1978) . The remainder of the sequence is proposed to form two loops around each calcium ion (Fig. 10 ). In this model the oxygen atoms of the D residues at the octahedral vertices x, y, z, -x , and -z form the calcium-binding site as they do in parvalbumin and related proteins (Kretsinger, 1980) . There is one additional amino acid between the -x and -z coordinates in the first loop. A similar insertion occurs in the calciumbinding site of the gamma-subunit of fibrinogen (Dang et al., Figure 6 . Isolation of a thrombospondin receptor from human endothelial cells. Endothelial cell membranes were radiolabeled with t25I-lactoperoxidase, extracted with 200 mM n-octylglucoside, and applied to a column of thrombospondin-Sepharose. The elution of the column is described in Material and Methods. The quantity of the 100,000-D protein was determined from densitometric scan of the autoradiograph. The initial lanes could not be quantitated because of the high level of background radioactivity. Note small increase in all of the radioactive binds after fraction 17 is probably due to a decrease in the flow rate that is done to conserve peptides. 1985). The second loop brings the two C residues into close proximity. We propose that these C residues form a disulfide bond which stabilizes the loop.
In the model proposed in Fig. 10 , the D residue of the RGD cell binding domain is one of the residues proposed to be involved in calcium binding. Assuming that calcium does, in fact, bind to this residue, there must be a mechanism that enables the D residue also to participate in the interaction with the cell surface receptor. This could be accomplished by a simple, competitive mechanism if the receptor affinity is high enough. Alternatively, it is possible that a calcium or magnesium ion also participates in the interaction with the cell surface receptor such that a calcium-binding site is formed by sequences from thrombospondin and its receptor. The ct-subunits of the integrin family of adhesive protein receptors have calcium-binding sites that are similar in terms of amino acid sequence to those found in thrombospondin (Fitzgerald et al., 1987; Suzuki et al., 1987; Poncz et al., 1987) .
The location of the RGD sequence within the type 3 repeat may have some implications for its evolutionary origin in thrombospondin. The RGD sequence occurs at positions 12-14 within the repeat (Lawler and Hynes, 1986) . The GD sequence occurs at positions 13 and 14 of all of the type 3 repeats, suggesting that these residues are important for calcium binding. amino acids, suggesting that this position can vary without loss of calcium-binding activity. We hypothesize that the seven type 3 repeats were formed by a series of endoduplications of a primordial gene that encoded a calcium-binding motif. The amino acids that were not specifically involved in calcium binding were free to diverge. When an R residue arose in position 12 of the last type 3 repeat, thrombospondin obtained the ability to intract with cell surfaces via an existing family of receptors. The data presented here indicate that the GPIIb-IIIa-like complex on the surface of endothelial and smooth muscle cells functions as an RGD-dependent receptor for thrombospondin. These results and the data of Cheresh (1987) suggest that thrombospondin, vitronectin, fibrinogen, and von WiUebrand factor interact with a common integrin receptor on endothelial cells. However, this conclusion needs to be forwarded with caution. Since the members of the 133 subfamily are very similar to each other and share a common I~ subunit, it is common for antibodies that have been raised against one member to cross react with other members of the subfamily. Antibodies that were raised against platelet GPIIb-IIIa inhibit the binding of thrombospondin to platelets (Plow et al., 1985) . However, thrombasthenic platelets bind normal levels of thrombospondin (Aiken et al., 1986) . This raises the possibility that the vitronectin, thrombospondin, fibrinogen, and von Willebrand receptors are similar but distinct entities. The monoclonal antibody LM609 reacts with the 133 integrin complex found on endothelial cells, smooth muscle cells, and melanoma cells (Cheresh, 1987; Cheresh and Spiro, 1987) . This antibody does not immunoprecipitate the GPIIb-IIIa complex on platelets or the vitronectin receptor on MG63 osteosarcoma cells (Cheresh, 1987; Cheresh and Spiro, 1987) .
Whereas the data presented here are consistent with previous studies in establishing that thrombospondin can support attachment of cells, most previous studies have not demonstrated an RGD effect (Varani et al., 1986; Roberts et al., 1987; Tuszynski et al., 1987) . Santoro (1987) has reported that the attachment of platelets to thrombospondin is inhibited by an RGD-containing peptide. By contrast, Roberts et al. (1987) have reported that GRGDSP did not inhibit the attachment and spreading of G361 melanoma cells to thrombospondin. A possible explanation for the differential effects of GRGDSP is that the G361 melanoma cells are binding to thrombospondin by a mechanism that is distinct from the mechanism employed by the cell types included in this study. Thrombospondin has been shown to interact with cell surfaces by several different mechanisms. Globular regions at both the NH2-and COOH-terminal have been implicated in platelet aggregation or cell attachment and spreading (Lawler, 1986; Roberts et al., 1987) .
A cell surface receptor for thrombospondin has recently been purified from C32 melanoma cells and platelets by Asch et al. (1987) . The receptor is an 88,000-D glycoprotein and is apparently identical to platelet membrane glycoprotein IV (GPIV). The interaction of thrombospondin with GPIV is inhibited by EGTA, as is cell attachment of the cell types included in this study (Asch et al., 1987) . However, the interaction with isolated GPIV is not inhibited by the synthetic peptide RGDS. Several hypotheses can be proposed to reconcile these data. The purification of GPIV may have induced a conformational change that has resulted in the loss of RGD specificity. Alternatively, another component of the membrane may bind to GPIV in much the same way GPIIb and GPIIIa form a complex. Such an additional component might confer RGD specificity. A third possibility is that GPIV is not functioning as the receptor in cell attachment assays. GPIV has been isolated from C32 melanoma cells by immunoaffinity columns prepared with the monoclonal antibody OKM5 (Asch et al., 1987) . Roberts et al. (1987) have reported that antibody OKM5 does not inhibit attachment of C32 melanoma cells to thrombospondin.
The results presented here indicate that the RGD sequence of thrombospondin is active in supporting cell attachment. Furthermore, the ability of the RGD sequence to support attachment is dependent upon the preservation of calciumdependent structures in thrombospondin. Whereas divalent cations have been shown to be important to the interaction of adhesive proteins with the integrin family of cell surface receptors, the divalent cations generally bind to the or-subunits of these receptors. Thrombospondin represents the first example of divalent cation modulation of the RGD in the ligand. It is currently unclear how divalent cation concentration could be regulated in an extracellular environment. One possibility is that glycosaminoglycans could bind divalent cations and affect their local concentration. Alternatively, calcium binding may not be a regulatory mechanism for these proteins. The calcium ion may be a component of the native molecule that confers conformational stability or resistance to proteolysis.
